Intestinal Disorders News

Heat waves were associated with an increased risk for inflammatory bowel disease relapse and incidence of infectious gastroenteritis in a recent retrospective, observational study.

The FDA has approved an Investigational New Drug application for phase 2 testing of microbiota restoration therapy for Clostridium difficile infection, according to a press release.

Patients with autism who exhibit gastrointestinal symptoms have a less rich and diverse gut microbiome than neurotypical patients, according to recent results.

The FDA has approved labeling changes to drugs containing olmesartan medoxomil, warning of the potential for intestinal problems, according to a press release.

Recipients of new oral anticoagulants, including dabigatran and rivaroxaban, may be more likely to experience gastrointestinal bleeding, according to a recent study.

Recipients of new oral anticoagulants, including dabigatran and rivaroxaban, may be more likely to experience gastrointestinal bleeding, according to a recent study.

Patients who experienced acute infectious gastroenteritis were more likely to develop functional dyspepsia later, according to recent results.

ORLANDO, Fla. — Patients with irritable bowel syndrome who experienced abdominal bloating had significantly different intestinal microbiota composition than those without bloating, according to data presented at Digestive Disease Week.

ORLANDO, Fla. — Incidence and risk factors for cardiovascular disease were less prevalent among patients with celiac disease than controls in a study presented at Digestive Disease Week.

Increased levels of trimethylamine-N-oxide are associated with increased risk for incident major adverse CV events, according to new data published in The New England Journal of Medicine.